150 related articles for article (PubMed ID: 33887113)
1. Adjustment by hematocrit level in calculation of removal rate in therapeutic apheresis.
Sakurasawa T; Ohkubo A; Hoshikawa Y; Yamauchi D; Yamamoto H; Seshima H; Kurashima N; Iimori S; Rai T; Uchida S; Naito S
Ther Apher Dial; 2021 Aug; 25(4):425-431. PubMed ID: 33887113
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
[TBL] [Abstract][Full Text] [Related]
3. Removal Dynamics of Immunoglobulin and Fibrinogen by Conventional Plasma Exchange, Selective Plasma Exchange, and a Combination of the Two.
Miyamoto S; Ohkubo A; Seshima H; Maeda T; Itagaki A; Kurashima N; Iimori S; Naito S; Sohara E; Rai T; Uchida S; Okado T
Ther Apher Dial; 2016 Aug; 20(4):342-7. PubMed ID: 27523073
[TBL] [Abstract][Full Text] [Related]
4. The selective therapeutic apheresis procedures.
Sanchez AP; Cunard R; Ward DM
J Clin Apher; 2013 Feb; 28(1):20-9. PubMed ID: 23420592
[TBL] [Abstract][Full Text] [Related]
5. Removal Dynamics of Autoantibodies, Immunoglobulins, and Coagulation Factors by Selective Plasma Exchange on Three Consecutive Days.
Miyamoto S; Ohkubo A; Seshima H; Yamamoto H; Itagaki A; Maeda T; Kurashima N; Mori T; Iimori S; Naito S; Sohara E; Rai T; Uchida S; Okado T
Ther Apher Dial; 2018 Jun; 22(3):255-260. PubMed ID: 29781127
[TBL] [Abstract][Full Text] [Related]
6. Effects of different lipoprotein apheresis methods on serum protein levels.
Julius U; Siegert G; Kostka H; Schatz U; Hohenstein B
Atheroscler Suppl; 2015 May; 18():95-102. PubMed ID: 25936311
[TBL] [Abstract][Full Text] [Related]
7. Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis.
Berger B; Hottenrott T; Leubner J; Dersch R; Rauer S; Stich O; Prüss H
BMC Neurol; 2015 Dec; 15():255. PubMed ID: 26830688
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Therapeutic Apheresis for Cryoglobulinemic Vasculitis Patients with Renal Involvement: A Systematic Review.
Miao J; Krisanapan P; Tangpanithandee S; Thongprayoon C; Cheungpasitporn W
Blood Purif; 2024; 53(1):1-9. PubMed ID: 37852193
[TBL] [Abstract][Full Text] [Related]
9. Erythrocyte apheresis in combination with elimination of fibrinogen and plasma proteins of higher molecular weight in macular disease and in uveal effusion syndrome.
Brunner R; Borberg H; Kadar J; Heidel M; Heidner K; Konen W
Acta Med Austriaca; 1991; 18 Suppl 1():63-5. PubMed ID: 1950392
[TBL] [Abstract][Full Text] [Related]
10. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
[TBL] [Abstract][Full Text] [Related]
11. Influence of atorvastatin versus simvastatin on fibrinogen and other hemorheological parameters in patients with severe hypercholesterolemia treated with regular low-density lipoprotein immunoadsorption apheresis.
Otto C; Geiss HC; Donner MG; Parhofer KG; Schwandt P
Ther Apher; 2000 Jun; 4(3):244-8. PubMed ID: 10910028
[TBL] [Abstract][Full Text] [Related]
12. A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathy.
Lieker I; Slowinski T; Harms L; Hahn K; Klehmet J
J Clin Apher; 2017 Dec; 32(6):486-493. PubMed ID: 28485075
[TBL] [Abstract][Full Text] [Related]
13. Calculations in apheresis.
Neyrinck MM; Vrielink H;
J Clin Apher; 2015 Feb; 30(1):38-42. PubMed ID: 25041907
[TBL] [Abstract][Full Text] [Related]
14. Change in therapeutic apheresis practices: Role of continuing medical education (CME).
Tiwari AK; Dara RC; Pandey P; Arora D; Rawat G; Raina V
J Clin Apher; 2016 Feb; 31(1):16-21. PubMed ID: 25858284
[TBL] [Abstract][Full Text] [Related]
15. Advances in apheresis therapy for glomerular diseases.
Yokoyama H; Wada T; Zhang W; Yamaya H; Asaka M
Clin Exp Nephrol; 2007 Jun; 11(2):122-127. PubMed ID: 17593511
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of different low-density lipoprotein apheresis methods.
Parhofer KG; Geiss HC; Schwandt P
Ther Apher; 2000 Oct; 4(5):382-5. PubMed ID: 11111821
[TBL] [Abstract][Full Text] [Related]
18. How to optimize lipoprotein apheresis treatment--a second look.
Schettler V; Neumann CL; Hagenah GC; Schulz EG; Wieland E
Atheroscler Suppl; 2013 Jan; 14(1):89-92. PubMed ID: 23357148
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Apheresis in Immunologic Renal and Neurological Diseases.
Bambauer R; Latza R; Burgard D; Schiel R
Ther Apher Dial; 2017 Feb; 21(1):6-21. PubMed ID: 28078733
[TBL] [Abstract][Full Text] [Related]
20. The Barcelona Hospital Clínic therapeutic apheresis database.
Cid J; Carbassé G; Cid-Caballero M; López-Púa Y; Alba C; Perea D; Lozano M
J Clin Apher; 2018 Jun; 33(3):259-264. PubMed ID: 28940696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
